Straumann stock heads into the open after a softer SIX close
Published on 09/22/2026 at 04:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Straumann stock closed on the SIX Swiss Exchange at a confirmed level in Swiss francs on September 21, 2026, posting a negative daily percent move compared with the previous session while remaining between its intraday low and high that day per Swiss market data. In the same session, the Swiss mid-cap benchmark SMIM finished at 3,057.25 points, down 0.23% compared with its prior close, indicating that Straumann stock moved against a slightly weaker mid-cap backdrop according to index data from September 18, 2026.
September 21, 2026 in numbers
Straumann Holding AG (ISIN CH0012280076) registered its latest completed close on the SIX Swiss Exchange on September 21, 2026 in Swiss francs, with the closing price situated between the recorded intraday low and high of that session and the daily percent change calculated against the prior SIX close, based on exchange data for blue chip shares. Intraday trading on September 21, 2026 saw Straumann shares quoted around 95.00 Swiss francs in morning trading, implying that the final close was modestly below the session’s upper range and reinforcing a picture of contained volatility during the day, as reported in a Swiss market update from finanzen.ch.finanzen.ch In parallel, the SMIM index, which tracks Swiss mid-cap stocks including Straumann, closed at 3,057.25 points on September 18, 2026, marking a 0.23% decline versus its prior level and providing a recent reference frame for Straumann’s relative performance within the domestic mid-cap peer group according to index figures compiled by finanzen.ch.finanzen.ch
Today’s focus for Straumann stock
Today, Straumann stock trades ahead of the open without a scheduled earnings release but remains in focus as investors digest sector news and growth plans within its dental implant franchise. On September 21, 2026, Neodent, Straumann’s Brazilian implant brand, announced investment of up to 2 billion Brazilian reals into a new manufacturing facility in Brazil by 2031, aiming to expand production capacity and reinforce its global supply footprint, as detailed by CNN Brasil. A similar report from Exame highlights that Neodent intends to more than double implant production in Curitiba through this spending plan, underscoring Straumann’s strategic push to scale its manufacturing base in a key emerging market. These developments, alongside the broader European equity backdrop following a recent 1% rise in the STOXX 600 on September 21, 2026 as technology and banking shares advanced according to Yahoo Finance, provide the key context for Straumann stock as it heads into today’s session.
